three
year
pandem
major
advanc
made
understand
innat
adapt
immun
respons
influenza
viru
respons
contribut
immunopatholog
associ
infect
sever
diseas
character
earli
secret
proinflammatori
immunomodulatori
cytokin
cytokin
secret
persist
patient
sever
viral
pneumonia
directli
associ
degre
viral
replic
respiratori
tract
cytokin
play
import
role
antivir
defens
persist
hypercytokinemia
may
caus
inflammatori
tissu
damag
particip
genesi
respiratori
failur
observ
patient
absenc
preexist
protect
antibodi
rule
mild
sever
case
role
pathogen
immunocomplex
propos
diseas
defect
cell
respons
character
sever
case
infect
caus
influenza
viru
immun
alter
associ
accompani
condit
obes
pregnanc
chronic
obstruct
pulmonari
diseas
may
interfer
normal
develop
specif
respons
viru
role
host
immunogenet
factor
associ
diseas
sever
also
discuss
review
conclus
current
avail
inform
suggest
complex
immunolog
dysfunctionalter
character
sever
case
pandem
influenza
potenti
benefit
prophylact
therapeut
intervent
aim
preventingcorrect
dysfunct
warrant
investig
elsevi
sl
right
reserv
r
e
u
e
n
el
posterior
estudio
de
la
gripe
de
hasta
la
actualidad
ha
dado
como
fruto
un
mayor
conocimiento
de
la
respuesta
innata
adaptativa
al
viru
de
la
gripe
de
la
de
la
respuesta
la
asociada
con
esta
se
ha
comprobado
que
la
enfermedad
grave
se
caracteriza
por
la
de
citocina
proinflamatoria
e
inmunomoduladora
desd
el
principio
de
la
enfermedad
en
lo
pacient
con
viral
grave
la
de
citocina
se
mantuvo
estaba
relacionada
directament
con
el
grado
de
viral
en
el
tracto
respiratorio
si
bien
la
citocina
tienen
un
papel
important
en
la
defensa
antivir
sin
embargo
la
persistencia
de
hipercitoquinemia
pued
el
tejido
inflamatorio
ser
uno
de
lo
motivo
que
provocan
el
fracaso
respiratorio
observado
en
esto
pacient
en
casi
todo
lo
caso
leve
grave
de
enfermedad
se
ausencia
de
anticuerpo
protector
preexistent
se
ha
propuesto
que
lo
inmunocomplejo
tienen
un
papel
en
esta
enfermedad
lo
caso
grave
de
causado
por
el
viru
de
la
gripe
se
caracterizan
por
una
respuesta
defectuosa
de
la
en
el
desarrollo
normal
de
la
respuesta
al
viru
pueden
interferir
trastorno
asociado
con
situacion
concomitant
como
obesidad
embarazo
enfermedad
pulmonar
obstructiva
lo
autor
de
esta
plantean
el
papel
que
tienen
lo
factor
del
en
la
gravedad
de
la
enfermedad
la
gripe
de
de
acuerdo
con
la
dispon
tard
se
caracteriza
por
una
compleja
por
lo
que
lo
potencial
beneficio
de
la
intervencion
deben
ir
dirigido
corregir
dicha
siempr
garantizado
mediant
la
elsevi
sl
todo
lo
derecho
reservado
appear
first
pandem
twentyfirst
centuri
caus
new
variant
influenza
virusinfluenza
repres
challeng
health
system
scientif
commun
reveal
dramat
import
effect
approach
prevent
viral
infect
major
influenza
infect
mild
selflimit
natur
small
percentag
patient
requir
hospit
special
attent
intens
care
unit
icu
although
mortal
rate
season
influenza
gener
low
tend
occur
extrem
age
life
children
elderli
clinic
epidemiolog
studi
show
pandem
vast
major
sever
case
occur
young
adult
import
accompani
comorbid
risk
factor
sever
diseas
follow
infect
influenza
viru
confirm
mani
studi
three
year
later
major
advanc
made
understand
innat
adapt
immun
respons
influenza
viru
host
respons
viru
contribut
immunopatholog
assess
use
anim
cellular
model
addit
increas
number
studi
describ
immun
respons
associ
sever
human
diseas
studi
reveal
complex
balanc
immun
protect
immunemedi
damag
diseas
immun
system
design
protect
maintain
homeostasi
abil
organ
adapt
environ
therefor
play
key
role
viral
clearanc
infect
respiratori
tract
caus
activ
nonspecif
tlrmediat
innat
immun
respons
first
line
defens
invad
virus
later
cours
infect
adapt
immun
respons
would
specif
elimin
viru
gener
longterm
immun
memori
viru
howev
evid
potenti
role
host
immun
respons
contributor
tissu
damag
respiratori
failur
observ
sever
case
caus
influenza
infect
author
previous
identifi
specif
host
immun
respons
signatur
sever
mild
sever
acut
respiratori
syndrom
cov
respiratori
syncyti
viru
infect
studi
sever
diseas
fatal
character
earli
hyperexpress
chemokin
cytokin
involv
antivir
respons
articl
review
current
avail
knowledg
immunopathogenesi
influenza
begin
pandem
absenc
avail
inform
role
play
host
immun
respons
viral
clearanc
immunopathogenesi
result
urgent
need
studi
address
issu
inform
vitro
cellular
model
first
arriv
initi
report
influenza
viru
compar
season
influenza
strain
poor
induc
cytokin
human
macrophag
dendrit
cell
respiratori
epitheli
cell
contrast
evid
come
later
clinic
studi
patient
infect
pandem
viru
point
limit
cellular
model
first
report
publish
decemb
reveal
sever
diseas
caus
influenza
viru
character
presenc
high
system
level
cytokin
chemokin
immun
mediat
earli
stage
diseas
studi
confirm
find
identifi
hypercytokinemia
host
respons
signatur
sever
pandem
influenza
fig
infect
influenza
viru
induc
secret
antivir
defenserel
chemokin
chemotact
molecul
mobil
lymphocyt
monocyt
macrophag
neutrophil
site
infect
fight
infect
howev
accumul
cell
may
contribut
inflammatorymedi
damag
infect
tissu
infect
patient
also
exhibit
elev
level
proinflammatori
immun
mediat
stimul
helper
interferon
ifn
gamma
tumour
necrosi
factor
interleukin
il
adapt
immun
play
central
defens
role
intracellular
microb
virus
may
necessari
influenza
viru
clearanc
infect
hand
cytokin
may
chemokin
contribut
tissu
injuri
studi
cytokin
profil
also
reveal
elev
relat
cytokin
earli
cours
sever
case
pneumonia
caus
immun
import
function
antibacteri
antivir
defens
also
involv
pathogenesi
sever
autoimmuneallerg
diseas
system
lupu
erythematosu
asthma
howev
benefici
role
lethal
influenza
previous
propos
addit
granulocyt
colonystimul
factor
gcsf
describ
interf
synthesi
report
directli
associ
risk
death
critic
ill
patient
contrari
describ
protect
factor
mortal
result
thu
support
imbalanc
proand
respons
sever
pandem
influenza
highlight
import
regul
axi
diseas
regard
fairli
broad
consensu
literatur
cytokin
potenti
biomark
sever
influenza
infect
human
mous
studi
elev
system
level
strongli
associ
icu
admiss
fatal
outcom
describ
present
bronchoalveolar
lavag
sever
patient
mice
infect
influenza
consist
trigger
sever
diseas
increas
level
lung
serum
furthermor
anim
clinic
studi
global
gene
express
analysi
indic
pronounc
inflammatori
respons
pleiotrop
cytokin
significantli
implic
variou
facet
immun
respons
implic
cytokin
storm
follow
avian
influenza
sever
acut
respiratori
syndrom
infect
level
associ
symptom
durat
sever
case
season
influenza
infect
avail
inform
thu
seem
point
toward
detriment
role
high
level
mediat
pathogenesi
infect
pandem
viru
howev
knockout
mous
model
recent
demonstr
absenc
signific
major
clinic
repercuss
suggest
play
essenti
nonredund
role
influenza
infect
mice
absenc
data
anim
model
overexpress
respons
influenza
infect
preclud
definit
conclus
pathogen
role
diseas
sever
case
show
earli
increas
vascular
endotheli
growth
factor
vegf
level
blood
potent
angiogen
factor
stimul
hypox
patient
thought
increas
permeabl
bronchial
airway
epithelium
follow
infect
respiratori
virus
case
sever
pandem
influenza
diseas
also
mark
high
level
immunomodulatori
cytokin
secret
molecul
may
repres
attempt
prevent
prolong
inflammatori
damag
promot
releas
cytokin
chemokin
altern
may
viral
mechan
evas
host
immun
respons
associ
pharyng
viral
secret
host
cytokin
respons
sever
pandem
influenza
diseas
character
poor
control
viru
earli
moment
infect
absenc
previou
protect
antibodi
moreov
numer
studi
found
sever
patient
unabl
reduc
viral
load
late
stage
diseas
despit
antivir
treatment
suggest
poor
control
viru
onset
infect
idea
reinforc
observ
associ
persist
viru
excret
patholog
sever
patient
turn
occur
fatal
case
infect
influenza
viru
level
viru
secret
respiratori
tract
directli
associ
cytokin
level
blood
begin
diseas
reinforc
notion
immun
dysfunct
sever
pandem
influenza
hypercytokinemia
persist
sever
case
could
perpetu
inflammatori
damag
consequ
respiratori
failur
observ
patient
similarli
clinic
studi
demonstr
high
plasma
level
correl
extent
progress
pneumonia
sever
case
also
show
persist
viral
shed
indic
poor
control
viral
replic
one
strike
featur
pandem
low
proport
elderli
individu
infect
new
viru
compar
season
influenza
addit
sever
ill
caus
new
variant
predomin
young
patient
death
occur
patient
year
old
contrari
normal
trend
season
influenza
believ
adult
born
ie
year
old
suffer
previou
exposur
antigen
relat
influenza
virus
develop
consequ
crossreact
antibodi
abil
recogn
strain
studi
antibodi
preval
show
presenc
crossreact
antibodi
much
popul
addit
studi
reveal
molecular
basi
crossreact
pandem
virus
articl
author
suggest
antibodi
viru
recogn
hemagglutinin
pandem
virus
result
consist
fact
young
adult
admit
icu
pandem
lack
protect
antibodi
earli
stage
diseas
reveal
hemagglutin
inhibit
hai
microneutr
assay
howev
absenc
earli
hai
neutral
activ
rule
young
patient
independ
diseas
sever
outcom
import
note
critic
patient
abl
mount
specif
antibodi
respons
pandem
viru
regardless
sever
suggest
factor
develop
specif
antibodi
contribut
pathogenesi
sever
pandem
influenza
sever
diseas
middleag
adult
explain
basi
preexist
crossreact
antibodi
low
affin
influenza
would
abl
block
viru
instead
would
form
pathogen
immunocomplex
would
accumul
lung
trigger
inflamm
crossreact
lymphocyt
th
lymphocyt
cytotox
lymphocyt
ctl
establish
vaccin
campaign
natur
infect
season
influenza
viru
report
contribut
clearanc
viru
lung
even
absenc
protect
antibodi
respons
individu
vaccin
season
influenza
may
still
benefit
preexist
crossreact
memori
cell
thu
reduc
suscept
influenza
viru
effector
cell
essenti
viru
clearanc
turn
may
contribut
hypercytokinemia
observ
sever
case
caus
influenza
infect
fact
studi
murin
model
demonstr
deplet
cell
prevent
immunopatholog
although
decreas
viral
clearanc
turn
cell
known
releas
cytotox
molecul
granzym
perforin
antivir
cytokin
essenti
mediat
elimin
infect
cell
howev
variou
studi
indic
releas
molecul
may
also
contribut
mediat
lung
patholog
exampl
mice
defici
epitheli
earli
growth
respons
develop
lung
injuri
suggest
role
erk
kinas
induc
immunopatholog
mediat
ctl
addit
experiment
infect
ko
mice
produc
lower
level
inflammatori
mediat
rant
show
milder
lung
infiltr
ctl
increas
surviv
rate
similarli
small
report
human
autopsi
tissu
document
diffus
alveolar
damag
hemorrhag
necrot
bronchiol
lung
patient
die
influenza
infect
immunohistolog
examin
reveal
aberr
immun
respons
associ
mark
express
larg
number
cell
granzym
b
cell
within
lung
tissu
highlight
role
cellular
immun
respons
immunopatholog
influenza
infect
cell
influenza
patient
present
sever
clinic
cours
describ
result
impair
effector
cell
differenti
fail
respond
mitogen
stimul
addit
cell
anergi
observ
sever
acut
phase
infect
adapt
immun
respons
influenza
patient
report
character
decreas
blymphocyt
increas
tregulatori
lymphocyt
latter
cell
may
suppress
develop
specif
respons
viru
addit
critic
pandem
influenza
ill
cours
lower
express
white
blood
cell
wbc
group
gene
key
develop
antigen
present
adapt
immun
respons
find
may
reflect
state
peripher
immunedefici
sever
pandem
influenza
altern
respond
redistribut
wbc
lung
case
hypoexpress
human
leukocyt
antigen
hla
tcellrel
gene
peripher
blood
constitut
molecular
signatur
sever
pandem
influenza
may
help
identifi
patient
risk
develop
complic
diseas
defici
cellular
immun
occur
sever
case
influenza
infect
could
help
explain
poor
control
viru
observ
patient
increas
risk
patient
suffer
bacteri
overinfect
chronic
obstruct
pulmonari
diseas
copd
asthma
cardiovascular
diseas
hypertens
diabet
report
risk
factor
critic
ill
follow
infect
pandem
viru
addit
pandem
pregnanc
obes
smoke
identifi
risk
factor
sever
chronic
respiratori
diseas
copd
asthma
character
basal
predisposit
releas
inflammatori
mediat
result
cell
cultur
mous
model
previous
demonstr
high
level
cytokin
could
prevent
develop
appropri
immun
respons
virus
affect
dendrit
cell
function
along
hlaii
mediat
antigen
present
mous
model
copd
anim
infect
influenza
viru
show
exacerb
inflammatori
respons
infect
addit
risk
associ
obes
cardiovascular
diseas
diabet
immunolog
alter
obes
may
contribut
role
risk
factor
influenza
pandem
adipocyt
structur
similar
immun
cell
perform
certain
function
relat
releas
inflammatori
mediat
furthermor
differenti
macrophag
adipos
tissu
condit
metabol
environ
immun
cell
turn
abl
control
lipid
glucos
metabol
suggest
immun
metabol
axi
chronic
calor
excess
could
interfer
mechan
immun
respons
obes
mice
infect
pandem
viru
exhibit
signific
higher
morbid
mortal
compar
nonobes
mice
pregnanc
number
chang
induc
immun
system
mother
aim
toler
fetu
although
chang
immun
system
fulli
understood
believ
may
increas
sever
infect
pregnant
women
balanc
proand
antiinflammatori
factor
seem
key
addit
chang
peripher
level
immun
mediat
tnf
vegf
gcsf
eotaxin
may
impact
proper
perform
immun
respons
increas
mortal
detect
pregnant
femal
mice
infect
influenza
viru
associ
increas
infiltr
neutrophil
macrophag
lung
anim
addit
pregnant
mice
show
higher
level
chemokin
proinflammatori
cytokin
lower
respiratori
epitheli
regener
poorer
fetal
develop
nonpregn
mice
therefor
basal
immun
alter
andor
presenc
previou
proinflammatori
state
favor
presenc
condit
copd
obes
pregnanc
may
impact
normal
develop
specif
immun
respons
viru
increas
risk
develop
sever
form
infect
although
studi
systemat
evalu
influenc
genet
polymorph
suscept
infect
avail
data
suggest
host
immunogenet
variat
may
play
import
role
final
outcom
follow
infect
viru
recent
review
author
propos
potenti
immun
dysfunct
caus
underli
genet
polymorph
may
lead
impair
respons
would
therefor
associ
advers
outcom
tabl
issu
gener
discuss
context
pandem
influenza
use
steroid
macrolid
treatment
complic
case
use
steroid
relat
increas
risk
bacteri
coinfect
use
associ
signific
clinic
benefit
patient
pneumonia
caus
pandem
viru
previous
report
condit
character
high
oxid
stress
presenc
high
level
proinflammatori
cytokin
steroid
longer
activ
therefor
role
steroid
treatment
diseas
caus
pandem
viru
current
recommend
macrolid
receiv
consider
attent
antiinflammatori
immunomodulatori
action
beyond
antibacteri
effect
benefit
still
uncertain
wide
spectrum
respiratori
viral
infect
shown
macrolid
reduc
viral
titer
downmodul
secret
cytokin
secondari
infect
rhinoviru
respiratori
syncyti
viru
influenza
thu
postul
reduct
proinflammatori
cytokin
may
modul
influenzavirusinduc
inflamm
sever
diseas
pediatr
patient
suffer
influenza
infect
addit
clarithromycin
oseltamivir
augment
product
secretori
immunoglobulin
siga
restor
local
siga
level
enhanc
mucos
immun
respons
children
clinic
assay
includ
patient
sever
infect
requir
intens
care
treatment
infect
convalesc
plasma
reduc
respiratori
tract
viral
load
serum
cytokin
respons
mortal
provid
evid
protect
effect
hyperimmun
serum
treatment
diseas
anoth
possibl
treatment
sever
case
caus
influenza
virus
hemoperfus
hemoperfus
use
polymyxin
bimmobil
fiber
column
pmx
shown
case
report
reduc
level
inflammatori
mediat
plasma
improv
oxygen
particular
pmx
hemoperfus
reduc
highmorbid
group
box
level
describ
therapeut
target
anim
model
sever
influenza
use
immunomodulatori
drug
open
major
avenu
develop
therapi
combin
antivir
treatment
influenza
infect
new
kind
treatment
base
reduc
inflammatori
mediat
highlight
import
role
hypercytokinemia
patholog
diseas
encourag
research
use
target
therapeut
strategi
combat
inflamm
resolv
diseas
caus
pandem
viru
vast
major
patient
develop
complic
diseas
pandem
nonvaccin
individu
preexist
protect
antibodi
light
inform
present
review
pandem
influenza
vaccin
may
offer
addit
benefit
reduc
number
individu
among
patient
risk
develop
complic
also
normal
popul
thu
suggest
wide
vaccin
coverag
approach
face
futur
pandem
avail
evid
suggest
deregulatedalt
immun
respons
patient
suffer
sever
form
pandem
influenza
diseas
respons
character
exacerb
secret
proinflammatori
immunomodulatori
cytokin
earlyinn
phase
respons
viru
deregul
cell
respons
develop
specif
adapt
immun
alter
translat
poor
control
infect
creat
viciou
circl
viral
replic
cytokin
product
viral
escap
could
perpetu
inflammationmedi
tissu
damag
respiratori
failur
fig
individu
environment
factor
caus
alter
immun
respons
remain
elucid
